These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 9486382)

  • 1. [Transitory evoked and distortion products of otoacoustic emissions in absent auditory evoked potentials].
    Schöler C; Schönweiler R; Ptok M
    HNO; 1997 Dec; 45(12):1008-15. PubMed ID: 9486382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Specificity and sensitivity of transient click-evoked otoacoustic emissions (TEOAE)].
    Pröschel U; Eysholdt U
    Laryngorhinootologie; 1995 Aug; 74(8):481-8. PubMed ID: 7575899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pseudoemissions and false positive findings in measurement of transiently evoked otoacoustic emissions (TEOAE)].
    Frese KA; Reker U; Maune S
    Laryngorhinootologie; 2001 Dec; 80(12):734-9. PubMed ID: 11793271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of TEOAE and DPOAE measurements for the assessment of auditory thresholds in sensorineural hearing loss.
    Suckfüll M; Schneeweiss S; Dreher A; Schorn K
    Acta Otolaryngol; 1996 Jul; 116(4):528-33. PubMed ID: 8831837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and audiological findings in children with auditory neuropathy].
    Shehata-Dieler W; Völter C; Hildmann A; Hildmann H; Helms J
    Laryngorhinootologie; 2007 Jan; 86(1):15-21. PubMed ID: 17283495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiopathological significance of distortion-product otoacoustic emissions at 2f1-f2 produced by high- versus low-level stimuli.
    Avan P; Bonfils P; Gilain L; Mom T
    J Acoust Soc Am; 2003 Jan; 113(1):430-41. PubMed ID: 12558280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auditory neuropathy with preserved cochlear microphonics and secondary loss of otoacoustic emissions.
    Deltenre P; Mansbach AL; Bozet C; Christiaens F; Barthelemy P; Paulissen D; Renglet T
    Audiology; 1999; 38(4):187-95. PubMed ID: 10431904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Otoacoustic emissions, auditory evoked potentials, pure tone thresholds and speech intelligibility in cases of auditory neuropathy].
    Ptok M
    HNO; 2000 Jan; 48(1):28-32. PubMed ID: 10663046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in transient-evoked otoacoustic emission levels with negative tympanometric peak pressure in infants and toddlers.
    Prieve BA; Calandruccio L; Fitzgerald T; Mazevski A; Georgantas LM
    Ear Hear; 2008 Aug; 29(4):533-42. PubMed ID: 18469719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of preserved otoacoustic emissions in a child with unilateral idiopathic severe sensorineural hearing loss].
    Namysłowski G; Morawski K; Trybalska G
    Otolaryngol Pol; 1999; 53(1):101-5. PubMed ID: 10337167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostics of the cochlear amplifier by means of distortion product otoacoustic emissions.
    Janssen T; Niedermeyer HP; Arnold W
    ORL J Otorhinolaryngol Relat Spec; 2006; 68(6):334-9. PubMed ID: 17065826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cochlear receptor (microphonic and summating potentials, otoacoustic emissions) and auditory pathway (auditory brain stem potentials) activity in auditory neuropathy.
    Starr A; Sininger Y; Nguyen T; Michalewski HJ; Oba S; Abdala C
    Ear Hear; 2001 Apr; 22(2):91-9. PubMed ID: 11324847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of cochlear active mechanisms in tinnitus subjects with normal hearing sensitivity: multiparametric recording of evoked otoacoustic emissions and contralateral suppression.
    Paglialonga A; Del Bo L; Ravazzani P; Tognola G
    Auris Nasus Larynx; 2010 Jun; 37(3):291-8. PubMed ID: 19879078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Possibility for quantitative and frequency-specific assessment of auditory threshold with otoacoustic emissions].
    Dreher A; Suckfüll M; Schneeweiss S; Schorn K
    Laryngorhinootologie; 1997 Jan; 76(1):2-7. PubMed ID: 9156504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rare audiometry findings in progressive, monosymptomatic low frequency deafness].
    Hoppe U; Rosanowski F; Delb W; Iro H
    HNO; 2001 Sep; 49(9):739-43. PubMed ID: 11593776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of neonatal hearing impairment: evaluation of transient evoked otoacoustic emission, distortion product otoacoustic emission, and auditory brain stem response test performance.
    Norton SJ; Gorga MP; Widen JE; Folsom RC; Sininger Y; Cone-Wesson B; Vohr BR; Mascher K; Fletcher K
    Ear Hear; 2000 Oct; 21(5):508-28. PubMed ID: 11059707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between auditory threshold and evoked otoacoustic emissions.
    Wagner W; Plinkert PK
    Eur Arch Otorhinolaryngol; 1999; 256(4):177-88. PubMed ID: 10337508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contralateral suppression of transient-evoked otoacoustic emissions in children with sickle cell disease.
    Stuart A; Preast JL
    Ear Hear; 2012; 33(3):421-9. PubMed ID: 22246207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of a universal newborn hearing-screening programme based on multiple transient-evoked otoacoustic emissions and clinical brainstem response audiometry.
    Berninger E; Westling B
    Acta Otolaryngol; 2011 Jul; 131(7):728-39. PubMed ID: 21466262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.